Navigation Links
The 3 percent solution: Unpopular drug companies still push discovery

Madison, Wis. - John McNeish gives it a light-hearted spin when he talks about drug companies being one of the least trusted institutions in America.

"The polls say only 3 percent of the people in the country have a favorable view of drug companies," Pfizer executive McNeish told a group of about 75 people, mostly scientists, who gathered at Universit......

Full article >>> al for drug discovery," McNeish said.

While Pfizer has worked with mouse stem cells, it has not conducted experiments involving human stem cells. While McNeish and his colleagues see tremendous potential in working with such cells, they also see many financial and public policy risks.

The costs of bringing a drug to market are enormous, not counting the ads. Pfizer may unveil a c......

Full article >>> ncil and the Wisconsin Innovation Network. He is the former associate editor of the Wisconsin State Journal in Madison.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or op......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 09/12/05


Related biology technology :

1. National angel investment grew 11 percent in `06
2. Musicnotes reports 45 percent growth in 2006
3. Fiserv posts 30 percent quarterly loss
4. RedPrairie exec calls for 50 percent tax cut
5. Renaissance earnings down 46 percent
6. GE Healthcare third-quarter profits up 17 percent
7. Criticare reports 20.3 percent increase in sales
8. Rockwell Automation ups quarterly dividend by 36 percent
9. Its 99 percent certain: Research cannot rely on adult stem cells alone
10. A disgusting video: U.S. companies sell out Americans
11. Pre-eminent, web-based companies owe success to corporate venturing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
Breaking Biology Technology:
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):